C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer's Trust to Improve Alzheimer's Disease Diagnosis

·2h ago
Share:PostShare

LONDON--(BUSINESS WIRE)-- #Alzheimers--C2N Diagnostics, LLC ("C2N"), a pioneer in advanced diagnostic testing for brain health, and Cambridge Cognition, the neuroscience technology company, announce on World Alzheimer’s Day a partnership with The Alzheimer's Trust, a newly formed subsidiary of The Cancer Screening Trust, to address the urgent and growing burden of Alzheimer's disease and related dementias in the United Kingdom (UK).The collaboration creates an integrated, scalable pathway for earlier and more

B

Businesswire

Original source

Read full story

Related Stories

Health8h ago

Carinity Urges Dialogue During Dementia Action Week

Carinity Urges Dialogue During Dementia Action Week Mirage News Landmark dementia survey finds carers overwhelmed and lonely ABC News & Headlines – Australian Broadcasting Corporation Carers face dementia toll but there's 'joy to be had' The Canberra Times It’s time to talk about dementia Australian Government Department of Health, Disability and Ageing News Corp Australia launches second annual Think Again campaign Mumbrella

GGoogle News

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer